Kathryn JohnBull
Analyst · NOBLE Capital. Please go ahead
Yes, our general assessment of the budget proposals is that they are not surprisingly, extremely favorable to the agencies that really support Health & Human Services initiatives. So from our perspective, we think that, while we understand that there's quite a bit of the process to still play out to get to the final number, we think the general sentiment is that those programs are highly, highly supported and from a bipartisan perspective. And of course, so the veterans always enjoy strong support on both from both sides of the aisle, and they did get a very nice proposal for estimated increase in their budget. But in addition to that, not surprisingly, there's a substantial increase in the NIH funding, of course, in the ongoing as we said, consistently for the last several months, we are just exiting Phase I triage critical response and in fact, we may end up having to go back there a little bit, just given what's going on with the variants. But naturally, we expect that there will be a long tail for scientific analysis and study of the impact of those, of the coronavirus COVID-19. Both independently and its effect on comorbidities for the public health populations that we study. So, we're not surprised to see the increase. But we do think it validates that, the country is positioned and really focused on those sustaining health issues that really affect so many people. And we think we are extremely well positioned with the skills required to respond to those opportunities and just going back and doubling back a little bit on those IDIQs, Zach mentioned, really very gratifying. It was the intent of our first phase acquisition program to build a full set of capabilities to be prepared to fully respond even without reliance on teammates. So of course, we'll team where appropriate but our own independent capability to fully respond to those very large IDIQ vehicles and be positioned to have the hunting license as the past quarters mature. It was part – a key part of our fundamental strategy over the last few years. And it's, validated by now our response to those large RFPs. So, we're certainly bullish on the opportunities we enjoyed both organically and those things that will evolve out of the budget plus-ups that we see evolving.